Browse: Companies | People | Financial Organizations
Home > Financial Organizations > New Science Ventures

General Information

Websitenewscienceventure...
Phone212 950 2562
Email
Employees
Founded2004
DescriptionNY VC in early/late stage in performance

Funds

Offices

New York, USA
645 Madison Avenue
20th Floor
New York, NY, 10022
USA

People

Managing Partner
Senior Associate
Partner

Tags

New Science Ventures

New Science Ventures (NSV) is a New York-based venture capital firm which invests in both early and late stage companies using novel scientific approaches to address significant unmet needs and create order of magnitude improvements in performance. NSV manages over $125 million and has invested in more than 20 companies located in the US, Europe, India and China in the life sciences and information technology sectors.

Milestones

Investments

Company Date Round Size Participants
BioVex 3/09Series F$40M7
Seahorse Bioscience 3/09Series D$6M7
Achronix Semiconductor 10/08Series B$52M5
TherOx 2/08Series E$30M3
FlowCardia 8/07Series C$30M9
Achronix Semiconductor 2007Series A$25.4M4

Videos

Sources

  1. BioVex Raises $40 Million (fiercebiotech.com) [edit]
  2. Seahorse Bioscience lands $6M, buys BioProcessors Corp (masshightech.com) [edit]
  3. Achronix Completes First Close of $52 Million Series B Preferred Stock Financing (achronix.com) [edit]
  4. TherOx raises $30,000,000 (vcastocks.com) [edit]
  5. FlowCardia, Inc. Raises $30 Million In Series C Financing (flowcardia.com) [edit]
  6. Venture Beat (venturebeat.com) [edit]
Edit This Page
Last Edited 7/16/09

Revision History RSS Picture

External Links

Embed Widget

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy